Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gabrielli

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
American Journal of Cancer Research|November 9, 2020
Smart drug combinations for cervical cancer: dual targeting of Bcl-2 family of proteins and aurora kinasesJacklyn Yumol, Brian Gabrielli, Yaman Tayyar, et al.
Molecular and Cellular Biology|June 10, 2009
CtBPs promote cell survival through the maintenance of mitotic fidelityLee M Bergman, Charles N Birts, Matthew Darley, et al.
Transplantation|February 1, 2002
A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative diseaseTom B Sculley, Marion Buck, Brian Gabrielli, et al.
Cellular Signalling|August 21, 2015
JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phaseAlex Pinder, Dorothy Loo, Brittney Harrington, et al.
The Journal of Biological Chemistry|August 26, 2009
Cyclin A/cdk2 regulates adenomatous polyposis coli-dependent mitotic spindle anchoringHeather Beamish, Leonore de Boer, Nichole Giles, et al.
The Journal of Biological Chemistry|December 22, 2006
Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cellsBrian Gabrielli, Yu Qian Chau, Nichole Giles, et al.
Molecular Cancer Therapeutics|May 20, 2017
Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase InhibitorsDavid Martin, Sora Fallaha, Martina Proctor, et al.
The Journal of Biological Chemistry|October 6, 2009
MAPK pathway activation delays G2/M progression by destabilizing Cdc25BPuji Astuti, Tanya Pike, Charlotte Widberg, et al.
Cellular Signalling|March 26, 2013
Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cellsTanya Pike, Charlotte Widberg, Andrew Goodall, et al.
Oncogene|January 13, 2004
The EBNA-3 gene family proteins disrupt the G2/M checkpointKenia G Krauer, Andrew Burgess, Marion Buck, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
American Journal of Cancer Research|November 9, 2020
Smart drug combinations for cervical cancer: dual targeting of Bcl-2 family of proteins and aurora kinasesJacklyn Yumol, Brian Gabrielli, Yaman Tayyar, et al.
Molecular and Cellular Biology|June 10, 2009
CtBPs promote cell survival through the maintenance of mitotic fidelityLee M Bergman, Charles N Birts, Matthew Darley, et al.
Transplantation|February 1, 2002
A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative diseaseTom B Sculley, Marion Buck, Brian Gabrielli, et al.
Cellular Signalling|August 21, 2015
JIP4 is a PLK1 binding protein that regulates p38MAPK activity in G2 phaseAlex Pinder, Dorothy Loo, Brittney Harrington, et al.
The Journal of Biological Chemistry|August 26, 2009
Cyclin A/cdk2 regulates adenomatous polyposis coli-dependent mitotic spindle anchoringHeather Beamish, Leonore de Boer, Nichole Giles, et al.
The Journal of Biological Chemistry|December 22, 2006
Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cellsBrian Gabrielli, Yu Qian Chau, Nichole Giles, et al.
Molecular Cancer Therapeutics|May 20, 2017
Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase InhibitorsDavid Martin, Sora Fallaha, Martina Proctor, et al.
The Journal of Biological Chemistry|October 6, 2009
MAPK pathway activation delays G2/M progression by destabilizing Cdc25BPuji Astuti, Tanya Pike, Charlotte Widberg, et al.
Cellular Signalling|March 26, 2013
Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cellsTanya Pike, Charlotte Widberg, Andrew Goodall, et al.
Oncogene|January 13, 2004
The EBNA-3 gene family proteins disrupt the G2/M checkpointKenia G Krauer, Andrew Burgess, Marion Buck, et al.
Pageof 9